Válts MeRSZ+ -ra!

MeRSZ online
okoskönyvtár

Több száz tankönyv egy helyen.
Online. Bárhol. Bármikor.

Fazekas Tamás, Merkely Béla, Papp Gyula, Tenczer József (szerk.)

Klinikai szív-elektrofiziológia és aritmológia

Irodalom

  1. Sedlis, S. P.: Mechanisms of ventricular arrhythmias in acute ischemia and reperfusion. Cardiovasc. Clin., 1992, 22: 3–18.
  2. Davies, M. J., Thomas, A.: Thrombosis and acute coronary artery lesions in sudden cardiac ischemic death. N. Engl. J. Med., 1984, 310: 1137–1140.
  3. Epstein, S. E., Quyyumi, A. A., Bonow, R. O.: Sudden cardiac death without warning. N. Engl. J. Med., 1989, 321: 320–323.
  4. Neely, J. R., Rovetto, M. J., Oram, J. F.: Myocardial utilization of carbohydrate and lipids. Prog. Cardiovasc. Dis., 1972, 15: 289–329.
  5. Arnsdorf, M. F., Sawicki, G. J.: The effects of lysophosphatidylcholine, a toxic metabolite of ischemia, on the components of cardiac excitability in sheep Purkinje fibers. Circ. Res., 1981, 49: 16–30.
  6. Corr, P. B., Creer, M. H., Yamada, K. A. et al.: Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J. Clin. Invest., 1989, 83: 927–36.
  7. Cascio, W. E., Johnson, T. A., Gettes, L. S.: Electrophysiologic changes in ischemic ventricular myocardium: I. Influence of ionic, metabolic, and energetic changes. J. Cardiovasc. Electrophysiol., 1995, 6: 1039–1062.
  8. Kleber, A. G.: Resting membrane potential, extracellular potassium activity and intracellular sodium activity during acute global ischemia in isolated perfused guinea pig hearts. Circ. Res., 1983, 52: 442–450.
  9. Hill, J. L., Gettes, L. S.: Effect of acute coronary artery occlusion on local nyocardial extracellular K+ activity in swine. Circulation, 1980, 61: 768–778.
  10. Dominguez, G., Fozzard, H. A.: Influence of extracellular K+ concentration on cable properties and excitability of sheep cardiac Purkinje fibers. Circ. Res., 1970, 26: 565–574.
  11. Ehlert, F. A., Goldberger, J. J.: Cellular and pathophysiological mechanisms of ventricular arrhythmias in acute ischemia and infarction. P.A.C.E, 1997, 20: 966–975.
  12. Downar, E., Janse, M. J., Durrer, D.: The effect of acute coronary occlusion on subepicardial transmembrane potentials in the intact porcine heart. Circulation, 1977, 56: 217–224.
  13. Kleber, A. G., Janse, M. J., Van Capelle, F. J. L. et al.: Mechanism and time course of ST and TQ segment changes during acute regional myocardial ischemia in the pig heart determined by extracellular and intracellular recordings. Circ. Res., 1978, 42: 603–613.
  14. Lazzara, R., El-Sherif, N., Hope, R. R. et al.: Ventricular arrhythmias and electrophysiological consequences of myocardial ischemia and infarction. Circ. Res., 1978, 42: 740–749.
  15. Wojtczak, J.: Contractures and increase in internal longitudinal resistance of cow ventricular muscle induced by hypoxia. Circ. Res., 1979, 44: 88–95.
  16. Saffitz, J. E., Lerner, D. L., Yamada, K. A.: Gap junction distribution and regulation in the heart. In: Zipes, D. P., Jalife, J. (eds) Cardiac Electrophysiology: From Cell to Bedside, 4th Edition. Philadelphia, Saunders, 2004, 181–191.
  17. Holland, R. P., Brooks, H.: The QRS complex during myocardial ischemia: an experimental analysis in the porcine heart. J. Clin. Invest., 1976, 57: 541–550.
  18. Kaplinsky, E., Ogawa, S., Balke, C. W. et al.: Two periods of early ventricular arrhythmia in the canine acute myocardial infarction model. Circulation, 1979, 60: 397–403.
  19. Kleber, A. G., Reigger, C. B., Janse, M. J.: Electrical uncoupling and increase of extracellular resistance after induction of ischemia in isolated, aretrially perfused rabbit papillary muscle. Circ. Res., 1987, 61: 271–279.
  20. Carmeliet, E.: Cardiac ionic currents and acute ischemia: from channels to arrhythmias. Physiol. Rev., 1999, 79: 917–1017.
  21. Yan, G. X., Joshi, A., Guo, D. et al.: Phase 2 reentry as a trigger to initiate ventricular fibrillation during early acute myocardial ischemia. Circulation, 2004, 110: 1036–1041.
  22. Wu, J., Zipes, D. P.: Mechanisms of initiation of ventricular tachyarrhythmias. In: Zipes, D. P., Jalife, J. (eds) Cardiac Electrophysiology: From Cell to Bedside, 4th Edition. Philadelphia, Saunders, 2004, 380–389.
  23. Zaitsev, A. V.: Mechanisms of ischemic ventricular fibrillation: who’s the killer? In: Zipes, D. P., Jalife, J. (eds) Cardiac Electrophysiology: From Cell to Bedside. 4th Edition. Philadelphia, Saunders, 2004, 399–406.
  24. Tenczer, J., Littmann, L., Rohla, M. et al.: The effects of overdrive pacing and lidocaine on atrioventricular junctional rhythm in man: the role of abnormal automaticity. Circulation, 1985, 72: 480–486.
  25. Xing, D., Martins, J. B.: Triggered activity due to delayed afterdepolarizations in sites of focal origin of ischemic ventricular tachycardia. Am. J. Physiol. Heart. Circ. Physiol., 2004, 287: H2078–2084.
  26. Canyon, S. J., Dobson, G. P.: Protection against ventricular arrhythmias and cardiac death using adenosine and lidocaine during regional ischemia in the in vivo rat. Am. J. Physiol. Heart. Circ. Physiol., 2004, 287: H1286–295.
  27. De Ferrari, G.. M., Schwartz, P. J.: Autonomic nervous system and arrhythmias. Ann. N. Y. Acad. Sci., 1990, 601: 247–262.
  28. Terzic, A., Pucéat, M., Vassort, G. et al.: Cardiac α1-adrenoceptors: an overview. Pharmacol. Rev., 1993, 45: 147–175.
  29. Ando, M., Katare, R. G., Kakinuma, Y. et al.: Efferent vagal nerve stimulation protects heart against ischemia-induced arrhythmias by preserving connexin43 protein. Circulation, 2005, 112: 164–170.
  30. Hartikainen, J., Kuikka, J., Mantysaari, M. et al.: Sympathetic reinnervation after acute myocardial infarction. Am. J. Cardiol., 1996, 77: 5–9.
  31. Chen, L. S., Chen, P. S.: Nerve sprouting and cardiac arrhythmias. In: Zipes, D. P., Jalife, J. (eds) Cardiac Electrophysiology: From Cell to Bedside. 4th Edition. Philadelphia, Saunders, 2004, 299–305.
  32. Bigger, J. T., Dresdale, F. J., Heissenbuttel, R. H. et al.: Ventricular arrhythmias in ischemic heart disease: mechanism, prevalence, significance, and management. Prog. Cardiovasc. Dis., 1977, 19: 255–300.
  33. Pogwizd, S. M., Corr, P. B.: Reentrant and nonreentrant mechanisms contribute to arrhythmogenesis during early myocardial ischemia: results using three-dimensional mapping. Circ. Res., 1987, 61: 352–371.
  34. Wu, G., Littmann, L., Svenson, R. H. et al.: Computerized three-dimensional activation mapping study of spontaneous ventricular arrhythmias during acute myocardial ischemia in dogs: evidence against macroreentrant mechanism. J. Electrocardiol., 1995, 28: 115–130.
  35. Coronel, R., Wilms-Schopman, F. J. G., DeGroot, J. R.: Origin of ischemia-induced phase 1b ventricular arrhythmias in pig hearts. J. Am. Coll. Cardiol., 2002, 39: 166–176.
  36. Hansen, P. R.: Myocardial reperfusion injury: experimental evidence and clinical relevance. Eur. Heart. J., 1995, 16: 734–740.
  37. Littmann, L., Svenson, R. H., Gallagher, J. J. et al.: Modification of sinus node function by epicardial laser irradiation in dogs. Circulation, 1990, 81: 350–359.
  38. Grauer, L. E., Gershen, B. J., Orlando, M. M. et al.: Bradycardia and its complications in the prehospital phase of acute myocardial infarction. Am. J. Cardiol., 1973, 32: 607–611.
  39. Mark, A. L.: The Bezold-Jarisch reflex revisited: clinical implications of inhibitory reflexes originating in the heart. J. Am. Coll. Cardiol., 1983, 1: 90–102.
  40. Yu, P. N.: The acute phase of myocardial infarction. Cardiovasc. Clin., 1975, 7: 45–56.
  41. Yusuf, S., Peto, R., Lewis, J. et al.: Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog. Cardiovasc. Dis., 1985, 27: 335–371.
  42. The T. I. M. I. Study Group: Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (T. I. M. I.) Phase II Trial. N. Engl. J. Med., 1989, 320: 618–627.
  43. C. O. M. M. I. T. Collaborative Group. Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet, 2005, 366: 1622–1632.
  44. James, T. N.: Myocardial infarction and atrial arrhythmias. Circulation, 1961, 24: 761–776.
  45. Hod, H., Lew, A. S., Keltai, M. et al.: Early atrial fibrillation during evolving myocardial infarction: a consequence of impaired left atrial perfusion. Circulation, 1987, 75: 146–150.
  46. Brearley, W. D. Jr., Taylor, L. III, Littmann, L.: Acute myocardial infarction with precordial ST segment elevation: where is the culprit? Heart. Lung., 2006, 35: 427–429.
  47. Sakata, K., Kurihara, H., Iwamori, K. et al.: Clinical and prognostic significance of atrial fibrillation in acute myocardial infarction. Am. J. Cardiol., 1977, 80: 1522–1527.
  48. Wong, C. K., White, H. D., Wilcox, R. G. et al.: New atrial fibrillation after acute myocardial infarction independently perdicts death: the GUSTO-III experience. Am. Heart. J., 2000, 140: 878–885.
  49. Konecke, L. L., Knoebel, S. B.: Nonparoxysmal junctional tachycardia complicating acute myocardial infarction. Circulation, 1972, 45: 367–374.
  50. Peters, R. W.: Heart block in acute myocardial infarction. In: Francis GS, Alpert JS (eds). Modern Coronary Care. Little, Brown and Company, 1990, 177–193.
  51. Bilbao, F. J., Zabalza, I. E., Vilanova, J. R. et al.: Atrioventrucular block in posterior acute myocardial infarction: a clinicopathologic correlation. Circulation, 1987, 75: 733–736.
  52. Feigl, D., Ashkenazy, J., Kishon, Y.: Early and late atrioventricular block in acute inferior myocardial infarction. J. Am. Coll. Cardiol., 1984, 4: 35–38.
  53. Dubois, C., Pierard, L. A., Smeets, J. P. et al.: Long-term prognostic significance of atrioventricular block in inferior acute myocardial infarction. Eur. Heart. J., 1989, 10: 816–820.
  54. Berger, P. B., Ryan, T. J.: Inferior myocardial infarction: high-risk subgroups. Circulation, 1990, 81: 401–411.
  55. Tans, A. C., Lie, K. I., Durrer, D.: Clinical setting and prognostic significance of high degree atrioventricular block in acute inferior myocardial infarction: a study of 144 patients. Am. Heart. J., 1980, 99: 4–8.
  56. Bertolet, B. D., McMurtrie, E. B., Hill, J. A. et al.: Theophylline for the treatment of atrioventricular block after myocardial infarction. Ann. Intern. Med., 1995, 123: 509–511.
  57. Ritter, W. S., Atkins, J. M., Blomquist, C. G. et al.: Permanent pacing in patients with transient trifascicular block during acute myocardial infarction. Am. J. Cardiol., 1976, 38: 205–208.
  58. Lamas, G. A., Muller, J. E., Turi, Z. G. et al.: A simplified method to predict occurrence of complete heart block during acute myocardial infarction. Am. J. Cardiol., 1986, 57: 1213–1219.
  59. Roth, A., Miller, H. I., Glick, A. et al.: Rapid resolution of new right bundle branch block in acute anterior myocardial infarction patients after thrombolytic therapy. P.A.C.E, 1993, 16: 13–18.
  60. Antman, E. M., Anbe, D. T., Armstrong, P. W. et al.: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary. J. Am. Coll. Cardiol., 2004, 44: 671–719.
  61. Gregoratos, G., Abrams, J., Epstein, A. E. et al.: ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmic devices: summary article. Circulation, 2002, 106: 2145–2161.
  62. Rothfeld, E. L., Zucker, I. R., Parsonnet, V. et al.: Idioventricular rhythm in acute myocardial infarction. Circulation, 1968, 37: 203–209.
  63. Gorgels, A. P. M., Vos, M. A., Letsch, I. S. et al.: Usefulness of the accelerated idioventricular rhythm as a marker for myocardial necrosis and reperfusion during thrombolytic therapy in acute myocardial infarction. Am. J. Cardiol., 1988, 61: 231–235.
  64. Newby, K. H., Thompson, T., Stebbins, A. et al, for the GUSTO Investigators: Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. Circulation, 1998, 98: 2567–2573.
  65. Al-Khafib, S. M., Granger, C. B., Huang, Y. et al.: Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes. Circulation, 2002, 106: 309–312.
  66. Rahimi, K., Watzlawek, S., Thiele, H. et al.: Incidence, time course, and predictors of early malignant ventricular arrhythmias after non-ST-segment elevation myocardial infarction in patients with early invasive treatment. Eur. Heart. J., 2006, 27: 1706–1711.
  67. Dekker, L. R., Bezzina, C. R., Henriques, J. P. et al.: Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients. Circulation, 2006, 114: 1140–1145.
  68. Kaikkonen, K. S., Kortelainen, M. L., Linna, E. et al.: Family history and the risk of sudden cardiac death as a manifestation of an acute coronary event. Circulation, 2006, 114: 1462–1467.
  69. Mont L, Cinca J, Blanch P, et al.: Predisposing factors and prognostic value of sustained monomorphic ventricular tachycardia in the arly phase of acute myocardial infarction. J. Am. Coll. Cardiol., 1996, 28: 1670–1676.
  70. Henkel, D. M., Witt, B. J., Gersch, B. J. et al.: Ventricular arrhythmias after acute myocardial infarction: a 20-year community study. Am. Heart J., 2006, 151: 806–812.
  71. Volpi, A., Cavalli, A., Santoro, L. et al, on behalf of the GISSI-2 Investigators.: Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction. Am. J. Cardiol., 1998, 82: 265–271.
  72. Littman, L., Rennyson, S. L.: Elektrical storm: clinical manifestations and management. Minerva Med., 2007, 98: 489–501.
  73. Halkin, A., Roth, A., Lurie, I. et al.: Pause-dependent torsade de pointes following acute myocardial infarction: a variant of the acquired long QT syndrome. J. Am. Coll. Cardiol., 2001, 38: 1168–1174.
  74. Teo, K. K., Yusuf, S., Furberg, C. D.: Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: an overview of results from randomized controlled trials. JAMA, 1993, 270: 1589–1595.
  75. Ryden, L., Ariniego, R., Arnman, K. et al.: A double-blind trial of metoprolol in acute myocardial infarction: effects on tachyarrhythmias. N. Engl. J. Med., 1983, 308: 614–618.
  76. Sadowski, Z. P., Alexander, J. H., Skrabucha, B. et al.: Multicenter randomized trial and systematic overview of lidocaine in acute myocardial infarction. Am. Heart. J., 1999, 137: 792–798.
  77. The 2005 International Consensus on Cardiopulmonary Resuscitation (CPR) and Emergency Cardiovascular Care (ECC) Science with Treatment Recommendations. Circulation, 2005, 112: III. 1–136.
  78. Zipes, D. P., Camm, A. J., Borggrefe, M. et al.: ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary. J. Am. Coll. Cardiol., 2006, 48: 1064–1108.
  79. Bansch, D., Oyang, F., Antz, M. et al.: Successful catheter ablation of electrical storm after myocardial infarction. Circulation, 2003, 108: 3011–3016.
  80. Callans, D. J., Josephson, M. E.: Ventricular tachycardia in patients with coronary artery disease. In: Zipes, D. P., Jalife, J. (eds) Cardiac Electrophysiology: From Cell to Bedside. 4th Edition. Philadelphia, Saunders, 2004, 569–574.
  81. Josephson, M. E.: Clinical Cardiac Electrophysiology: Techniques and Interpretations. 2nd Edition. Philadelphia, Lea & Febiger, 1993.
  82. Zheng, Z. J., Croft, J. B., Giles, W. H. et al.: Sudden cardiac death in the United States, 1989 to 1998. Circulation, 1998, 104: 2158–2163.
  83. Littmann, L., Svenson, R. H., Gallagher, J. J. et al.: High grade entrance and exit block in an area of healed myocardial infarction associated with ventricular tachycardia with successful laser photoablation of the anatomic substrate. Am. J. Cardiol., 1989, 64: 122–124.
  84. De Bakker, J. M. T., van Capelle, F. J. L., Janse, M. J. et al.: Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation, 1988, 77: 589–606.
  85. Littmann, L., Svenson, R. H., Gallagher, J. J. et al.: Functional role of the epicardium in postinfarction ventricular tachycardia: observations derived from computerized epicardial activation mapping, entrainment, and epicardial laser photoablation. Circulation, 1991, 83: 1577–1591.
  86. Svenson, R. H., Littmann, L., Colavita, P. G. et al.: Laser photoablation of ventricular tachycardia: correlation of diastolic activation times and photoablation effects on cycle length and termination – observations supporting a macroreentrant mechanism. J. Am. Coll. Cardiol., 1992, 19: 607–613.
  87. Rothman, S. A., Hsia, H. H., Cossu, S. F. et al.: Radiofrequency catheter ablation of postinfarction ventricular tachycardia: long-term success and the significance of inducible nonclinical arrhythmias. Circulation, 1997, 96: 3499–3508.
  88. Svenson, R. H., Littmann, L., Gallagher, J. J. et al.: Termination of ventricular tachycardia with epicardial laser photocoagulation: a clinical comparison with patients undergoing successful endocardial photocoagulation alone. J. Am. Coll. Cardiol., 1990, 15: 163–170.
  89. Levine, J. H., Massumi, A., Scheinman, M. M. et al.: Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. J. Am. Coll. Cardiol., 1996, 27: 67–75.
  90. Stevenson, W. G.: Ventricular tachycardia after myocardial infarction: from arrhythmia surgery to catheter ablation. J. Cardiovasc. Electrophysiol., 1995, 6: 942–950.
  91. Sosa, E., Scanavacca, M., d’Avila, A. et al.: Nonsurgical transthoracic epicardial catheter ablation to treat recurrent ventricular tachycardia occurring late after myocardial infarction. J. Am. Coll. Cardiol., 2000, 35: 1442–1449.
  92. Bayes de Luna, A. B., Coumel, P., Leclercq, J. F.: Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am. Heart J., 1989, 117: 151–159.
  93. Luu M, Stevenson WG, Stevenson LW, et al.: Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation, 1989, 80: 1675–1680.
  94. Mehta, D., Curwin, J., Gomes, J. A. et al.: Sudden death in coronary artery disease: acute ischemia versus myocardial substrate. Circulation, 1997, 96: 3215–3223.
  95. Maggioni, A. P., Zuanetti, G., Franzosi, M. G. et al.: Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era: GISSI-2 results. Circulation, 1993, 87: 312–322.
  96. Domanski, M. J., Exner, D. V., Borkowf, C. B. et al.: Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials. J. Am. Coll. Cardiol., 1999, 33: 598–604.
  97. Jánosi, A., Ghali, J. K., Herlitz, J. et al.: Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HF. Am. Heart J., 2003, 146: 721–728.
  98. Naccarelli, G. V., Lukas, M. A.: Carvedilol’s antiarrhythmic properties: therapeutic implications in patients with left ventricular dysfunction. Clin. Cardiol., 2005, 28: 165–173.
  99. Amiodarone Trials Meta-Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-anlysis of individual data from 6500 patients in randomised trials. Lancet, 1997, 350: 1417–1424.
  100. Lauer, M. R.: Dofetilide: is the treatment worse than the disease? J. Am. Coll. Cardiol., 2001, 37: 1106–1110.
  101. Echt, D. S., Liebson, P. R., Mitchell, L. B. et al.: Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N. Engl. J. Med., 1991, 324: 781–788.
  102. Waldo, A. L., Camm, A. J., deRuyter, H. et al.: for the SWORD investigators. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet, 1996, 348: 7–12.
  103. Kelly, P., Ruskin, J. N., Vlahakes, G. J. et al.: Surgical coronary revascularization in survivors of prehospital cardiac arrest: its effect on inducible ventricular arrhythmias and long-term survival. J. Am. Coll. Cardiol., 1990, 15: 267–273.
  104. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N. Engl. J. Med., 1997, 337: 1576–1583.
  105. Connolly, S. J., Gent, M., Roberts, R. S. et al.: Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation, 2000, 101: 1297–1302.
  106. Kuck, K. H., Cappato, R., Siebels, J. et al.: Randomized comparison of antiarrhythmia drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation, 2000, 102: 748–754.
  107. Moss, A. J., Hall, W. J., Cannom, D. S. et al.: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N. Engl. J. Med., 1996, 335: 1933–1940.
  108. Buxton, A. E., Lee, K. L., Fisher, J. D. et al.: A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N. Engl. J. Med., 1999, 341: 1882–1890.
  109. Moss, A. J., Zareba, W., Hall, W. J. et al.: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Engl. J. Med., 2002, 346: 877–883.
  110. Bardy, G. H., Lee, K. L., Mark, D. B. et al.: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med., 2005, 352: 225–237.
  111. Solomon, S. D., Zelenkofske, S., McMurray, J. J. V. et al.: Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N. Engl. J. Med., 2005, 352: 2581–2588.
  112. Hohnloser, S. H., Kuck, K. H., Dorian, P. et al.: Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N. Engl. J. Med., 2004, 351: 2481–2488.
  113. Wilber, D. J., Zareba, W., Hall, J. et al.: Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation, 2004, 109: 1082–1084.
  114. Goldenberg, I., Moss, A. J., McNitt, S. et al.: Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction. Am. J. Cardiol., 2006, 98: 485–490.
  115. Robin, J., Weinberg, K., Tiongson, J. et al.: Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients. Heart Rhythm., 2006, 3: 1196–1201.
  116. Singh, S. N., Poole, J., Anderson, J. et al.: Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure. Am. Heart J., 2006, 152: 974.e7–11.
  117. Moss, A. J.: Implantable cardioverter defibrillator therapy: the sickest patients benefit the most. Circulation, 2000, 101: 1638–1640.
  118. Hohnloser, S. H., Ikeda, T., Bloomfield, D. M. et al.: T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation. Lancet, 2003, 362: 125–126.
  119. Chow, T., Kereiakes, D. J., Bartone, C. et al.: Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy. J. Am. Coll. Cardiol., 2007, 49: 50–58.
  120. Goldenberg, I., Moss, A. J., McNitt, S. et al.: Inverse relationship of blood pressure levels to sudden cardiac mortality and benefit of the implantable cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J. Am. Coll. Cardiol., 2007, 49: 1427–1433.
  121. Moss, A. J.: Everyone with an ejection fraction less than or equal to 30% should receive an implantable cardioverter-defibrillator. Circulation, 2005, 111: 2542–2548.
  122. Buxton, A. E.: Not everyone with an ejection fraction ≤ 30% should receive an implantable cardioverter-defibrillator. Circulation, 2005, 111: 2537–2542.
  123. Stevenson, L. W., Desai, A. S.: Selecting patients for discussion of the ICD as primary prevention for sudden death in heart failure. J. Card. Failure, 2006, 12: 407–412.
  124. Stevenson, L. W.: Implantable cardioverter-defibrillators for primary prevention of sudden death in heart failure: are there enough bangs for the bucks? Circulation, 2006, 114: 101–103.
  125. Butler, J., Leon, A.: The elusive scourge of sudden cardiac death: is rational decision making possible? Should there be standards of risks and predictions in medicine? J. Am. Coll. Cardiol., 2007, 49: 1434–1435.
Klinikai szív-elektrofiziológia és aritmológia

Tartalomjegyzék

Kiadó: Akadémiai Kiadó

Online megjelenés éve: 2016

ISBN: 978 963 059 748 7

Orvostudomány

A Klinikai szív-elektrofiziológia és aritmológia első kiadását a szívritmuszavarok patofiziológiájában, farmakológiájában, diagnosztikájában és gyógyításában kiemelkedően jártas hazai szakírók vetették papírra. Az aritmiában szenvedő betegek optimális ellátásához nélkülözhetetlen, az idő tájt rendelkezésre álló elméleti és klinikai tudnivalókat átfogóan ismertető kézikönyv iránti olvasói érdeklődés és a Magyar Tudományos Akadémia Orvosi Osztályának Nívódíja bizonyította, hogy a szerzők és a szerkesztők erőfeszítései nem voltak haszontalanok. Egy évtized az élettudományok fejlődésének jelenlegi tempóját figyelembe véve nagyon hosszú idő. Az elektrofiziológia és (a)ritmológia mind a mai napig a szívgyógyászat egyik legdinamikusabban fejlődő technicizálódó ága, melynek vertikuma egyre nagyobb: a szívizom szabályos ritmikáját megzavaró, nemritkán öröklődő patobiokémiai eltérések felismerésétől az új típusú, innovatív gyógyszerek hozzáértő alkalmazásán keresztül az egyre kifinomultabb invazív terápiás eljárásokig ível. Ennélfogva idő- és szükségszerűvé vált a lényegbevágóan új diagnosztikai / képalkotó módszerek, gyógyszeres és instrumentális kezelési módozatok, valamint a nagy mintaszámú, randomizált, kontrollcsoportos arrhythmiavizsgálatok eredményein nyugvó és a szakmai tudományos irányelvek főbb útmutatásait visszatükröző ismeretek friss, kézikönyvbe foglalt szintézise: a tudományág fejlődésével lépést tartó jelen, második, új fejezetek beépítésével és a régebbiek újraírásával, felülvizsgálatával gazdagított kiadás megírása, összeállítása.

Hivatkozás: https://mersz.hu/fazekas-merkely-papp-tenczer-klinikai-sziv-elektrofiziologia-es-aritmologia//

BibTeXEndNoteMendeleyZotero
Kivonat
fullscreenclose
printsave